# FDA Inspection 1021732 - Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd - April 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/4330cf6e-8453-4f85-b122-5f6257657210
Source feed: FDA_Inspections

> FDA Inspection 1021732 for Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd on April 28, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021732
- Company Name: Chongqing Southwest No 2 Pharmaceutical Factory Co., Ltd
- Inspection Date: 2017-04-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1243715 - 2024-05-31](https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/4beff8dd-a276-4a7c-9e73-48ca404cefee)
- [FDA Inspection 985510 - 2016-07-28](https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/2bbc4699-a681-4a34-92c1-9cb3b3879896)
- [FDA Inspection 794375 - 2012-07-19](https://www.keypedia.com/records/fda_inspections/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/1884b835-6aab-4e21-b927-7c83492f3b53)

Company: https://www.keypedia.com/companies/chongqing-southwest-no-2-pharmaceutical-factory-co-ltd/dbcf7c68-8b86-427d-90cd-92c27afcb7fa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c